Finance

Lists
688091:SHA
Shanghai Yizhong Pharmaceutical Co Ltd
35,07 CN¥
+0,06%
(+0,020) 1D
16 հոկ, 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688091...
Open
35,38 CN¥
High
36,26 CN¥
Low
34,96 CN¥
Mkt. cap
7,24 մլրդ
Avg. vol.
2,77 մլն
Volume
1,78 մլն
P/E ratio
104,89
52-wk high
66,20 CN¥
52-wk low
33,80 CN¥
EPS
0,33 CN¥
No. of employees
457
Open
35,38 CN¥
High
36,26 CN¥
Low
34,96 CN¥
Mkt. cap
7,24 մլրդ
Avg. vol.
2,77 մլն
Volume
1,78 մլն
P/E ratio
104,89
52-wk high
66,20 CN¥
52-wk low
33,80 CN¥
EPS
0,33 CN¥
No. of employees
457
News stories
From web sources and news partners
About Shanghai Yizhong Pharmaceutical Co Ltd
CEO-
Employees457
Founded10 սեպ, 2009 թ.
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
82,82 մլն
72,95 մլն
79,16 մլն
86,68 մլն
Cost of goods sold
12,69 մլն
14,03 մլն
11,67 մլն
13,29 մլն
Cost of revenue
12,69 մլն
14,03 մլն
11,67 մլն
13,29 մլն
Research and development expenses
25,74 մլն
31,86 մլն
27,36 մլն
24,62 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
39,43 մլն
18,74 մլն
27,51 մլն
29,89 մլն
Operating expense
66,07 մլն
51,41 մլն
55,17 մլն
55,98 մլն
Total operating expenses
78,76 մլն
65,44 մլն
66,84 մլն
69,27 մլն
Operating income
4,06 մլն
7,51 մլն
12,32 մլն
17,41 մլն
Other non operating income
-1,06 մլն
1,06 մլն
-1,93 հզր
-1,23 հզր
EBT including unusual items
9,16 մլն
11,83 մլն
16,96 մլն
24,37 մլն
EBT excluding unusual items
7,11 մլն
12,82 մլն
17,38 մլն
21,10 մլն
Income tax expense
-3,50 մլն
-2,07 մլն
-1,21 մլն
229,63 հզր
Effective tax rate
-38,19%
-17,51%
-7,13%
0,94%
Other operating expenses
368,20 հզր
340,52 հզր
-202,15 հզր
1,03 մլն
Net income
12,65 մլն
13,90 մլն
18,17 մլն
24,14 մլն
Net profit margin
15,28%
19,05%
22,95%
27,85%
Earnings per share
-
-
-
-
Interest and investment income
4,10 մլն
4,34 մլն
5,18 մլն
3,80 մլն
Interest expense
-
-85,85 հզր
-112,57 հզր
-113,68 հզր
Net interest expenses
4,10 մլն
4,25 մլն
5,06 մլն
3,69 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
6,85 մլն
10,50 մլն
15,31 մլն
20,71 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps